Skip to main content

ALEMS · European Medical Solutions · Financials

3.6200 EUR -0.2800 (-7.18%) At close · Oct 6
Market Cap
17.77M EUR
Shares
4.23M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
35.27M -2.8%
FY2022 Revenue FY2021–FY2022
Net Income
-5.58M -2214.5%
FY2022 Net Income FY2021–FY2022
Operating Margin
-15% -15.1pp
FY2022 Operating Margin FY2021–FY2022
Operating Cash Flow
2.33M +568.4%
FY2022 Operating Cash Flow FY2021–FY2022

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2022 FY2021
EUR 35.27M 36.27M
EUR 696K 775K
EUR -5.29M 29K
EUR 482K 327K
EUR -5.58M -241K
EUR 0 -1000
EUR -5.58M -241K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2022: 521K in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of long-term borrowings 2022-12-31 EUR 4,447,000 ESEF Annual Report filed 2023-04-28
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.